These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 18638702)

  • 1. The globalization of ayahuasca: harm reduction or benefit maximization?
    Tupper KW
    Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
    Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
    J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.
    Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M
    Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
    Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
    Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
    Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
    Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
    Liester MB; Prickett JI
    J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
    Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I
    J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
    McIlhenny EH; Riba J; Barbanoj MJ; Strassman R; Barker SA
    Biomed Chromatogr; 2011 Sep; 25(9):970-84. PubMed ID: 21058415
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Malcolm BJ; Lee KC
    Ment Health Clin; 2017 Jan; 7(1):39-45. PubMed ID: 29955496
    [No Abstract]   [Full Text] [Related]  

  • 14. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    McIlhenny EH; Pipkin KE; Standish LJ; Wechkin HA; Strassman R; Barker SA
    J Chromatogr A; 2009 Dec; 1216(51):8960-8. PubMed ID: 19926090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
    Callaway JC
    J Psychoactive Drugs; 2005 Jun; 37(2):151-5. PubMed ID: 16149328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status of ayahuasca users.
    Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
    Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
    Freedland CS; Mansbach RS
    Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
    Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
    Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.